These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10502990

  • 1. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
    Matsumura T, Saito T, Miyai I, Nozaki S, Kang J.
    Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
    [Abstract] [Full Text] [Related]

  • 2. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T, Saito T, Miyai I, Nozaki S, Kang J.
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [Abstract] [Full Text] [Related]

  • 3. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH, Barber BJ, Spicer RL, Wong BL, Weidner N, Benson DW, Markham LW.
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [Abstract] [Full Text] [Related]

  • 4. [Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy].
    Kashiwagi S, Akaike M, Kawai H, Adachi K, Saito S.
    Rinsho Shinkeigaku; 1996 Jan; 36(1):7-11. PubMed ID: 8689797
    [Abstract] [Full Text] [Related]

  • 5. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE.
    Pharmacotherapy; 1993 Jan; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.
    Ogata H, Ishikawa Y, Ishikawa Y, Minami R.
    J Cardiol; 2009 Feb; 53(1):72-8. PubMed ID: 19167641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 11. A Case of Refractory Heart Failure in Becker Muscular Dystrophy Improved With Corticosteroid Therapy.
    Nakamura M, Sunagawa O, Hokama R, Tsuchiya H, Miyara T, Taba Y, Touma T.
    Int Heart J; 2016 Sep 28; 57(5):640-4. PubMed ID: 27535714
    [Abstract] [Full Text] [Related]

  • 12. [Alteration of atrial natriuretic peptide in progressive muscular dystrophy with congestive heart failure].
    Miyai I, Kang J, Nozaki S, Matsumura T.
    Rinsho Shinkeigaku; 1992 Jun 28; 32(6):588-92. PubMed ID: 1424336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA.
    Circulation; 2005 Nov 01; 112(18):2799-804. PubMed ID: 16246949
    [Abstract] [Full Text] [Related]

  • 15. [Cardiopulmonary failure in Duchenne muscular dystrophy--pathophysiology and management].
    Ishihara T.
    Rinsho Shinkeigaku; 2003 Nov 01; 43(11):761-4. PubMed ID: 15152458
    [Abstract] [Full Text] [Related]

  • 16. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A, Silverberg DS, Calabrò A, Spinelli T, Quatrini I, Campagna MS, Franci B, Nuti R.
    J Cardiovasc Pharmacol; 2009 Jun 01; 53(6):462-7. PubMed ID: 19455052
    [Abstract] [Full Text] [Related]

  • 17. Intravenous milrinone in treatment of advanced congestive heart failure.
    Zewail AM, Nawar M, Vrtovec B, Eastwood C, Kar MN, Delgado RM.
    Tex Heart Inst J; 2003 Jun 01; 30(2):109-13. PubMed ID: 12809251
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
    Brozena SC, Twomey C, Goldberg LR, Desai SS, Drachman B, Kao A, Popjes E, Zimmer R, Jessup M.
    J Heart Lung Transplant; 2004 Sep 01; 23(9):1082-6. PubMed ID: 15454175
    [Abstract] [Full Text] [Related]

  • 19. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F.
    Ital Heart J Suppl; 2000 Aug 01; 1(8):996-1002. PubMed ID: 10993005
    [Abstract] [Full Text] [Related]

  • 20. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 01; 11(6):429-32. PubMed ID: 19558803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.